Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P06889 (Mol)
 630,302 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

From 1984 to 1990, human breast cancer estrogen receptors have been measured both by a radioligand assay (RLA[3H]estradiol) and by an enzyme immunoassay (Abbott ER-EIA kit). The ratio EIA/RLA results increased continuously from 1.04 (1984) to 1.87 (1990), and this evolution was consistent with the last trial of the E.O.R.T.C. receptor study group (Trial 1989-II, EIA/RLA = 2.5). Dilution studies of cytosols with the current ER-EIA kits showed an important parallelism defect of the standard curve, the final result of cytosols (fmol/mg protein) obtained from the upper part of the curve (between 100 and 500 fmol/ml) being 1.5 to 2 times higher than the results obtained from readings of the lower part of the standard curve (between 0 and 50 fmol/ml). Chromatographic experiments were carried out during 1986 and the measures of binding sites by RLA and of immunoreactive sites by EIA on chromatographic fractions were compared. Identical results were obtained with EIA and RLA, either on polymeric forms of the estrogen receptor, or on monomeric forms obtained after dissociation by 0.4 M KCl. The same experiments performed during 1990 showed that, in the chromatographic fractions, the concentration of immunoreactive sites was twice as large as that of ligand-binding sites, detected by tritiated estradiol. Furthermore, the detection of polymeric and monomeric receptor isoforms by monoclonal antibodies varied, and was increased by the presence of KCl (0.4 M) and/or bovine serum albumin (BSA) (1 mg/ml) in the cytosol. These findings showed that the large differences between enzyme immunoassay and ligand-binding assay results currently observed were due to differential reactivity of monoclonal antibodies for the estrogen receptor standard provided in the ER-EIA kits and for the estrogen receptor present in cytosols from human breast cancers, suggesting modifications of immunoreactivity of the monoclonal antibodies actually provided in the ER-EIA kits.
J Steroid Biochem Mol Biol 1991 Oct
PMID:Evolution of immunoreactivity of monoclonal antibodies H222 and/or D547 used in the detection of breast cancer estrogen receptors. Varying reactivity of receptor isoforms. 191 41

Streptococcal protein G (SPG) shows specific binding activity to IgGs and serum albumins from various species. In order to investigate the structural domains of SPG responsible for the specific interaction with human IgG-Fab, the binding characteristics of a collection of recombinant receptors were analysed. The study includes receptors comprising different parts of the SPG molecule as well as chimeric receptors containing IgG-binding domains of staphylococcal protein A (SPA) fused to the N-terminal AB-region of SPG, which has been claimed to interact with human IgG-Fab. Purified defined gene products were allowed to compete for the binding to human IgG, human IgG-F(ab')2 fragments and human serum albumin (HSA) in several sets of competitive binding experiments. The results demonstrate that the C-terminal C domains have both IgG-Fc- and IgG-Fab-binding capacities, whereas the N-terminal AB region is responsible for the HSA-binding only. These results, which are in conflict with previous work, demonstrate that the binding to both the IgG-Fc and the IgG-Fab region is mediated by the same structurally distinct receptor region of SPG.
Mol Immunol 1991 Oct
PMID:Structural and functional analysis of the human IgG-Fab receptor activity of streptococcal protein G. 192 1

Suramin is a polyanionic compound which has been used in the treatment of trypanosomiasis and acquired immunodeficiency syndrome (AIDS), while preliminary success has been reported in the treatment of cancer. However, suramin also causes adrenal insufficiency. We have previously reported that suramin selectively inhibited corticotropin (ACTH)-stimulated corticosterone release by dispersed adrenal cells in a dose-dependent manner via a direct interaction with the ACTH molecule. The present study was undertaken in order to investigate the effect of suramin on hormone release by dispersed rat anterior pituitary cells. Suramin at a concentration of 100 microM inhibited both basal and secretagogue-stimulated ACTH release by cells cultured in minimal essential medium (MEM) only, while it had no effect on ACTH release by cells cultured in MEM + 10% fetal calf serum (FCS) or MEM + 0.1% bovine serum albumin (BSA). In addition, suramin also caused a parallel decrease of prolactin (PRL) and growth hormone (GH) release by cells cultured in MEM only, suggesting a toxic, rather than a selective effect of suramin on anterior pituitary cells cultured in MEM only. In addition, suramin potentiated the effect of thyrotropin-releasing hormone (TRH) on PRL release by cells cultured in MEM + 10% FCS and suppressed the inhibitory effect of dopamine (DA) on PRL release by cells cultured in MEM + 10% FCS and in MEM + 0.1% BSA. Comparable suppressive effects of suramin on growth hormone-releasing hormone (GHRH)-stimulated and somatostatin (SRIH)-inhibited GH release were found in cells cultured in MEM + 0.1% BSA but not in cells cultured in MEM + 10% FCS.(ABSTRACT TRUNCATED AT 250 WORDS)
Mol Cell Endocrinol 1990 Aug 20
PMID:Effects of suramin on hormone release by cultured rat anterior pituitary cells. 198 Aug 98

A complex cell culture environment has been shown to maintain the differentiated state of hepatocytes, yet the mechanisms by which environmental cues selectively maintain liver-specific gene transcription have been unknown. In this paper we show that the hepatic environment regulates the activities of at least three liver-enriched transcription factors, eE-TF, eG-TF/HNF3, and eH-TF, that activate the mouse serum albumin enhancer. eE-TF is a heat-stable factor that has a DNA-binding specificity similar to that of the liver transcription factor C/EBP, but is a distinct protein. eG-TF/HNF3 contributes to the liver-specific transcription of several other serum protein genes. eH-TF binds to a TGTTTGC sequence that occurs at regulatory sites of the albumin promoter, the hepatitis B virus enhancer, and other hepatic genes. eE-TF, eG-TF/HNF3, and eH-TF are regulated by different combinations of the following cell culture conditions: a hormonally defined serum-free medium; an extracellular matrix gel; and a transformation-competent simian virus 40 large T antigen. We propose a regulatory network model to explain how cues from the cell lineage and the extracellular environment coordinately help maintain the activities of transcription factors involved in hepatocyte differentiation.
Mol Cell Biol 1991 Feb
PMID:Extracellular signals that regulate liver transcription factors during hepatic differentiation in vitro. 199 Feb 82

A microtitre plate enzyme immunoassay (EIA) for plasma estradiol is described, involving competition between sample estradiol and an immobilized estradiol-bovine serum albumin complex for a monoclonal anti-estradiol antibody, followed by immobilized antibody quantitation using enzyme-labelled antiglobulins. The assay dose-response curve covered a range of 6-1500 fmol/well. The intra- and inter-assay coefficient of variation for the assay of three plasma pools ranged from 3.1 to 4.7% and from 4.7 to 10.6% respectively. The assay showed satisfactory correlation with a standard estradiol radioimmunoassay. Pre-coated microtitre plates were stable, dried, at 4 degrees C for up to 3 months and the anti-estradiol was stable to lyophilization and also was stable in solution at 4 degrees C for up to 1 month.
J Steroid Biochem Mol Biol 1991 Mar
PMID:Enzyme immunoassay for plasma estradiol using a monoclonal antibody. 200 25

To discover the antigenicity-producing mechanism of acetylsalicylic acid, the interaction of this drug and relevant salicylic acid with human serum albumin (HSA) has been studied by means of nuclear magnetic resonance (NMR) spectroscopy. The determination of spin-lattice relaxation rates (1/T1) of some protons have revealed that one HSA molecule can bind acetylsalicylate and salicylate up to 80 and 290 molecules, respectively. The hydrolysis rates of acetylsalicylate were greatly enhanced in the presence of HSA, especially when the drug/HSA mole ratio was small. Thus, the esterase-like activity of HSA was verified. This activity of HSA was effectively inhibited by salicylate; the effect was ascribed to the stronger binding affinity of salicylate toward HSA as compared with that of acetylsalicylate. Based on these results, the antigenicity-producing mechanism of acetylsalicylate and salicylate has been discussed.
Mol Immunol
PMID:Acetylsalicylate-human serum albumin interaction as studied by NMR spectroscopy--antigenicity-producing mechanism of acetylsalicylic acid. 201 Nov 21

Attachment of cells to extracellular matrix (ECM) plays an important role in the regulation of cell growth and differentiated function. We hypothesized that bronchial epithelial cells preferentially attach to ECM proteins and utilize specific receptors for ECM proteins. Bronchial epithelial cells were obtained from bovine lung by protease digestion. Both freshly isolated and cultured bronchial epithelial cells were plated onto plastic petri dishes coated with bovine serum albumin, type I collagen, type IV collagen, fibronectin, laminin, ECM synthesized by cultured bronchial epithelial cells, or uncoated. Freshly isolated cells demonstrated significant attachment to ECM but weak attachment to other matrix proteins. Cultured bronchial epithelial cells attached well to ECM; however, they had relatively increased attachment to type I collagen, type IV collagen, fibronectin, and laminin compared to freshly isolated cells. To determine whether the attachment of bronchial epithelial cells is arginine-glycine-aspartic acid (RGD)-mediated, an RGD-containing peptide known to block attachment mediated by many integrin receptors was added to the media (400 micrograms/ml). There was no inhibition of attachment of freshly isolated cells; however, there was significant but not complete inhibition of the attachment of the cultured cells to type IV collagen, laminin, and fibronectin, but not to type I collagen or ECM. Thus, freshly isolated bronchial epithelial cells readily adhere to ECM, and the attachment does not appear to be mediated by RGD-dependent receptors. Cultured bronchial epithelial cells demonstrate increased attachment to component proteins of ECM, and this attachment is, in part, to RGD-dependent receptors.
Am J Respir Cell Mol Biol 1991 May
PMID:Attachment characteristics of bovine bronchial epithelial cells to extracellular matrix components. 202 81

The allylic steroid, 3 alpha-hydroxy-4-pregnen-20-one (3 alpha HP), found in gonadal and brain tissues by radiotracer and chemical methods, had been shown to play a role in gametogenesis, gonadotropin secretion and brain excitability. Since no simple assay was available, a radioimmunoassay for 3 alpha HP was developed using [3H]3 alpha HP and an antiserum raised against 3 alpha HP-20-CMO conjugated to bovine serum albumin. The specificity of the assay for the 3 alpha allylic configuration of 3 alpha HP was confirmed by examining 32 other steroids; cross-reaction with steroids containing different configurations (including metabolites of 3 alpha HP such as progesterone) was less than 0.9%. A Scatchard plot indicated a Ka of 1.56 X 10(9) M-1. Inter- and intra-assay coefficients of variation were 13.1 and 4.5%, respectively. The sensitivity of the assay was 6 pg and the 50% intercept of the standard curve was approx. 123 pg. The measurement by RIA of 3 alpha HP from standard solutions and HPLC purified tissue extracts was confirmed qualitatively and quantitatively by GC/MS methods. The RIA method was employed to determine 3 alpha HP levels in cultured Sertoli cells and in serum of intact and ovariectomized adult rats. Although for most uses, chromatography would not be necessary, two possible methods are presented to enable the separation of 3 alpha HP from other interfering steroids prior to RIA.
J Steroid Biochem Mol Biol 1991 Apr
PMID:A radioimmunoassay for the regulatory allylic steroid, 3 alpha-hydroxy-4-pregnen-20-one (3 alpha HP). 203 64

A series of neoglycoproteins was synthesized by coupling of thiophosgene-activated p-aminophenyl derivatives [Biol. Cell. 47:95-110 (1983); J. Histochem. Cytochem. 32:1091-1094 (1984)] of various sugars to human serum albumin. The compounds were evaluated for their in vitro activity against human immunodeficiency virus (HIV). Neoglycoproteins with the highest sugar content were found to be the most potent inhibitors of HIV-1-induced cytopathogenicity. However, this was not due to the nature of the sugar used but, rather, was related to the extra negative charge of the neoglycoproteins. To investigate whether the antiviral activity of the neoglycoproteins exhibited sugar specificity, increased with increasing negative charge, or depended on both sugar specificity and negative charge, we synthesized albumins and neoglycoproteins with an enhanced negative charge, by treatment with formaldehyde or succinic anhydride. Succinylated human serum albumin had the most pronounced net negative charge and had an IC50 of about 1 microgram/ml. No cytotoxicity was observed at concentrations up to 1 mg/ml, implicating a selectivity index (CC50/IC50) of at least 10(3). To elucidate the mechanism of action of these anionic albumins, we investigated whether they interfered with HIV-1 adsorption to the cells, binding of anti-OKT4A monoclonal antibody (mAb) to the CD4 receptor, binding of anti-gp120 mAb to gp120, or inhibition of syncytium formation in co-cultures of HIV-1-infected HUT-78 cells with MOLT-4 cells. From these experiments, we conclude that albumins with an increased negative charge (a) are potent and nontoxic anti-HIV-1 agents, (b) cause a 50% reduction of syncytium formation in the same concentration range as their IC50 in the antiviral assay, and (c) do not bind to the OKT4A epitope of the CD4 receptor and only partly inhibit anti-gp120 mAb-gp120 interaction and virus-cell binding at concentrations that are 100 times higher than their IC50 in the antiviral assay. Therefore, we conclude that the modified albumins interfere with a post-binding event, of which one of the potential mechanisms is an interaction with the gp41 fusion protein, which is necessary for syncytium formation but is not involved in initial virus binding.
Mol Pharmacol 1991 Jun
PMID:Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins. 205 94

This article attempts to review some of the advances made during the past few years in our understanding of the nature of the barrier presented by the endothelial cell wall and how it may contribute to the regulation of exchange between blood and tissues. It has concentrated on a small number of experimental techniques which have yielded information on the correlation between structure and function of the endothelial cell wall and which have emphasized the potentially dynamic characteristics of the barrier. Whilst there now seems to be little dispute as to the location of the fluid conducting channels across the endothelial cell wall, within the clefts, fenestrae and in inflammation the open cell junctions, it has proved difficult to identify the molecular filter which limits macromolecular exchange across these pathways. In fenestrated endothelium it has been suggested that the filter resides at the fenestral diaphragms or in the underlying basement membrane, while in continuous endothelium there is strong support in the literature that the filter is located within the intercellular cleft, at regions of closely apposed cell membranes, or in the case of a vesicular pathway, at the necks or diaphragms of the vesicle openings. Alternatively, there is a considerable and increasing body of experimental evidence that macromolecular movement is retarded by the endothelial cell coat which lines the whole of the endothelial cell surface and covers the openings of interendothelial cell clefts, fenestral diaphragms and vesicle openings. It is believed to comprise glycoproteins secreted and regulated by the endothelial cells themselves and to have associated with it plasma proteins, particularly serum albumin. Expression of this glycocalyx and its modification have been demonstrated in vivo and in cultures of isolated endothelial cells, in vitro. Experiments using single microvessels in which a correlation between structure and function can be most readily made, offer further evidence that the clefts between endothelial cells are quantitively more than sufficient in extent to accommodate the fluid fluxes measured in even the most highly permeable vessels. They further demonstrate that the dramatic increases in fluid flux seen in inflammation result from a modulation of endothelial cell shape to form interendothelial cell gaps by activation of intracellular contractile mechanisms, mediated by changes in intracellular calcium. Increases in macromolecular leakage may only be seen when gap formation is accompanied by extensive modulation of the intercellular cement substance, or glycocalyx filling those gaps.(ABSTRACT TRUNCATED AT 400 WORDS)
Prog Biophys Mol Biol 1991
PMID:Relationship between microvascular permeability and ultrastructure. 205 77


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>